跳至主要内容
临床试验/JPRN-UMIN000027428
JPRN-UMIN000027428招募中未知

Retrospective cohort study of resistance associated substitutions and clinical course in Glecaprevir(GLE)/Pibrentasvir(PIB) treatment to hepatitis C virus - RASs and clinical course in GLE/PIB treatment

Kyoto Prefectural University of Medicine Department of Molecular Gastroenterology and Hepatology0 个研究点目标入组 700 人开始时间: 2017年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients coinfection with human immunodeficiency virus, autoimmune hepatitis, primary biliary cirrhosis, hemochromatosis or Wilson's disease are excluded. Patients with uncontrollable other disease and those with alcohol abuse are also excluded.

研究者

发起方
Kyoto Prefectural University of Medicine Department of Molecular Gastroenterology and Hepatology

相似试验